These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25925376)

  • 1. The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.
    Lin SJ; Lin CY; Yang DR; Izumi K; Yan E; Niu X; Chang HC; Miyamoto H; Wang N; Li G; Chang C
    Neoplasia; 2015 Apr; 17(4):339-47. PubMed ID: 25925376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
    Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C
    Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases.
    Liu S; Lin SJ; Li G; Kim E; Chen YT; Yang DR; Tan MH; Yong EL; Chang C
    Endocr Relat Cancer; 2014 Jun; 21(3):R279-300. PubMed ID: 24623743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.
    Qiu X; Zhu J; Sun Y; Fan K; Yang DR; Li G; Yang G; Chang C
    Oncotarget; 2015 Jun; 6(17):15397-409. PubMed ID: 25980442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
    Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C
    J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
    Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
    Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.
    Zhu J; Yang DR; Sun Y; Qiu X; Chang HC; Li G; Shan Y; Chang C
    Mol Cancer Ther; 2015 Jun; 14(6):1445-53. PubMed ID: 25833838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of miR‑145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.
    Zhu J; Qin P; Cao C; Dai G; Xu L; Yang D
    Oncol Rep; 2021 Mar; 45(3):963-974. PubMed ID: 33650661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.
    Lin SJ; Yang DR; Li G; Chang C
    Front Endocrinol (Lausanne); 2015; 6():78. PubMed ID: 26074876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity.
    Chen D; Chou FJ; Chen Y; Tian H; Wang Y; You B; Niu Y; Huang CP; Yeh S; Xing N; Chang C
    Cancer Lett; 2020 Dec; 495():100-111. PubMed ID: 32768524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4.
    Lin SJ; Zhang Y; Liu NC; Yang DR; Li G; Chang C
    Mol Endocrinol; 2014 Jun; 28(6):805-21. PubMed ID: 24702179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation.
    Xie S; Lee YF; Kim E; Chen LM; Ni J; Fang LY; Liu S; Lin SJ; Abe J; Berk B; Ho FM; Chang C
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13353-8. PubMed ID: 19666541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
    Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
    Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TR
    Jin R; Lin H; Li G; Xu J; Shi L; Chang C; Cai X
    Cell Death Dis; 2018 Feb; 9(3):283. PubMed ID: 29449527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TR2 and TR4 Orphan Nuclear Receptors: An Overview.
    Lin SJ; Yang DR; Yang G; Lin CY; Chang HC; Li G; Chang C
    Curr Top Dev Biol; 2017; 125():357-373. PubMed ID: 28527578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression.
    Hu L; Sun Y; Luo J; He X; Ye M; Li G; Zhang Y; Bai J; Zhang D; Chang C
    Oncogene; 2020 Feb; 39(9):1891-1903. PubMed ID: 31748715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
    Yu S; Wang M; Ding X; Xia L; Chen B; Chen Y; Zhang Z; Niu Y; Li G; Chang C
    Prostate; 2015 Oct; 75(14):1632-42. PubMed ID: 26178291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the retinoic acid-induced cell apoptosis and differentiation by the human TR4 orphan nuclear receptor.
    Lee YF; Bao BY; Chang C
    Biochem Biophys Res Commun; 2004 Oct; 323(3):876-83. PubMed ID: 15381082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.
    Chen Y; Lu J; Xia L; Xue D; Yu X; Shen D; Xu L; Li G
    Cancer Sci; 2018 Feb; 109(2):384-394. PubMed ID: 29197138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression.
    Kim E; Ma WL; Lin DL; Inui S; Chen YL; Chang C
    Biochem Biophys Res Commun; 2007 Sep; 361(2):323-8. PubMed ID: 17655826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.